Halabi, S., Luo, B., Guo, S., Rydzewska, L. H. M., Godolphin, P. J., Parmar, M. K., … Sweeney, C. (2024). 1615P A new prognostic model of overall survival (OS) in patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC). In Annals of Oncology (Vol. 35, pp. S975–S975). Elsevier BV. https://doi.org/10.1016/j.annonc.2024.08.1696

Halabi, S., B. Luo, S. Guo, L. H. M. Rydzewska, P. J. Godolphin, M. K. Parmar, M. A. Carducci, et al. “1615P A new prognostic model of overall survival (OS) in patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC).” In Annals of Oncology, 35:S975–S975. Elsevier BV, 2024. https://doi.org/10.1016/j.annonc.2024.08.1696.

Halabi S, Luo B, Guo S, Rydzewska LHM, Godolphin PJ, Parmar MK, et al. 1615P A new prognostic model of overall survival (OS) in patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC). In: Annals of Oncology. Elsevier BV; 2024. p. S975–S975.

Halabi, S., et al. “1615P A new prognostic model of overall survival (OS) in patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC).” Annals of Oncology, vol. 35, Elsevier BV, 2024, pp. S975–S975. Crossref, doi:10.1016/j.annonc.2024.08.1696.

Halabi S, Luo B, Guo S, Rydzewska LHM, Godolphin PJ, Parmar MK, Carducci MA, Gravis G, James ND, Tierney JF, Sweeney C. 1615P A new prognostic model of overall survival (OS) in patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC). Annals of Oncology. Elsevier BV; 2024. p. S975–S975.